Advertisement

Topics

Merrimack Launches As New, Refocused Research & Clinical Development Company With Resources To Advance Prioritized Lead Pipeline Candidates MM-121, MM-141 And MM-310

20:00 EDT 2 Apr 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Merrimack Launches As New, Refocused Research & Clinical Development Company With Resources To Advance Prioritized Lead Pipeline Candidates MM-121, MM-141 And MM-310

NEXT ARTICLE

More From BioPortfolio on "Merrimack Launches As New, Refocused Research & Clinical Development Company With Resources To Advance Prioritized Lead Pipeline Candidates MM-121, MM-141 And MM-310"

Quick Search
Advertisement